NCT01998035 2024-08-22Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid MalignanciesColumbia UniversityPhase 1/2 Terminated58 enrolled 11 charts
NCT00079443 2013-07-01FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 2 Terminated60 enrolled